Komori

2026年3月期 第3四半期 決算説明資料

Results presentationNine months, FY ending Mar 2026Published 2026-02-16 15:30

2026年3月期第3四半期は、価格改定と診療数の堅調な推移、業務効率化により、売上高・各利益が前年同期を上回り、過去最高を更新した。営業利益は通期修正予想の93.0%まで進み、通期業績は予想を上回る見込みとされている。

Contents of this document

Earnings presentationFiscal year ending March 2026, third quarter7 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥4,660 million+18.2%
Operating profit¥966 million+63.8%
Ordinary income¥962 million+63.0%
Net income¥675 million+65.0%
Gross Profit Margin40.9 %
Operating profit margin20.7 %
Selling, general and administrative expenses¥940 million
Results for the three months of the current quarter
Net Sales
¥1,560 million
Operating profit margin
21.3 %
Full-year earnings forecast
Net Sales
¥6,100 million
Operating profit
¥1,040 million
Ordinary income
¥1,030 million
Profit attributable to owners of the parent
¥730 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales76.3%
Operating profit93.0%
Ordinary income93.5%
Profit attributable to owners of the parent92.5%
Number of initial consultations79.2%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
通期業績は前回発表予想を上回る見込み
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Revenue growth¥718 million
  • Personnel expenses¥150 million
  • Facilities and IT¥93 million
  • Depreciation and amortization¥19 million
  • Other¥79 million
New initiatives
  • Renovation of Nagoya Hospital
  • Expansion into Fukuoka
  • Development of a next-generation electronic medical records system
  • AIを活用した診療支援の検討
  • 統合CRMシステム基盤の設計
  • テルコム社による2026年10月の新機種投入と飼い主向けレンタル製品への認可拡大申請
  • 高度医療・献血ドナーの認知向上・啓発プロジェクト
Key KPIsA metric the company considers important as a management benchmark.
  • Number of initial consultations (referrals)8,364 transactions
  • Number of affiliated hospitals4,749 facilities
    Year on year against the same period last year+158施設
  • Affiliated hospital ratio37 %
  • Number of veterinarians providing secondary care101 people
Segment results
  • Secondary Veterinary Care Services
    Net Sales¥3,409 million
    Year-on-year revenue growth20.8
  • Diagnostic Imaging Services
    Net Sales¥474 million
    Year-on-year revenue growth16.2
  • 動物用医療機器・健康管理機器のレンタル・販売
    Net Sales¥766 million
    Year-on-year revenue growth9
Medium-term management plan targets
Hospital revenue
Fiscal year ending March 2027¥4,550 million
Consolidated revenue
Fiscal year ending March 2027¥6,200 million
Consolidated operating profit
Fiscal year ending March 2027¥1,040 million
ROE
Fiscal year ending March 202714% or higher
Financial targets
ROE
Target14% or higher
Actual results16.3 %
Contents of this document
ItemDetails
Document typeEarnings presentation
Fiscal Period CoveredFiscal year ending March 2026, third quarter
Net Sales¥4,660 million (YoY +18.2%)
Operating profit¥966 million (YoY +63.8%)
Ordinary income¥962 million (YoY +63.0%)
Net income¥675 million (YoY +65.0%)
Gross Profit Margin40.9 %
Operating profit margin20.7 %
Selling, general and administrative expenses¥940 million
Results for the three months of the current quarterNet Sales ¥1,560 million / Operating profit margin 21.3 %
Full-year earnings forecastNet Sales ¥6,100 million / Operating profit ¥1,040 million / Ordinary income ¥1,030 million / Profit attributable to owners of the parent ¥730 million
Progress against full-year forecastNet Sales 76.3% / Operating profit 93.0% / Ordinary income 93.5% / Profit attributable to owners of the parent 92.5% / Number of initial consultations 79.2%
Self-assessment against the plan通期業績は前回発表予想を上回る見込み
Segment resultsSegment Secondary Veterinary Care Services / Net Sales ¥3,409 million / Year-on-year revenue growth 20.8, Segment Diagnostic Imaging Services / Net Sales ¥474 million / Year-on-year revenue growth 16.2, Segment 動物用医療機器・健康管理機器のレンタル・販売 / Net Sales ¥766 million / Year-on-year revenue growth 9
Breakdown of Factors Affecting the ChangeFactors Revenue growth / Amount ¥718 million, Factors Personnel expenses / Amount ¥150 million, Factors Facilities and IT / Amount ¥93 million, Factors Depreciation and amortization / Amount ¥19 million, Factors Other / Amount ¥79 million
Key KPIsIndicator name Number of initial consultations (referrals) / Value 8,364 transactions / Year on year against the same period last year Not disclosed, Indicator name Number of affiliated hospitals / Value 4,749 facilities / Year on year against the same period last year +158施設, Indicator name Affiliated hospital ratio / Value 37 % / Year on year against the same period last year Not disclosed, Indicator name Number of veterinarians providing secondary care / Value 101 people / Year on year against the same period last year Not disclosed
Medium-term management plan targetsHospital revenue Fiscal year ending March 2027 ¥4,550 million / Consolidated revenue Fiscal year ending March 2027 ¥6,200 million / Consolidated operating profit Fiscal year ending March 2027 ¥1,040 million / ROE Fiscal year ending March 2027 14% or higher
Financial targetsROE Target 14% or higher / Actual results 16.3 %
New initiativesRenovation of Nagoya Hospital, Expansion into Fukuoka, Development of a next-generation electronic medical records system, AIを活用した診療支援の検討, 統合CRMシステム基盤の設計, テルコム社による2026年10月の新機種投入と飼い主向けレンタル製品への認可拡大申請, 高度医療・献血ドナーの認知向上・啓発プロジェクト
Items this document does not state (12)
Unit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

2026年3月期 第3四半期 決算説明資料 | Japan Animal Referral Medical Center Co.,Ltd. (6039) timely disclosure | Komori